Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bupivacaine 50mg/Adrenaline (base) 50microg/10ml inj amp
1502010C0AAAJAJ
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 1,997 |
|
Bupivacaine 25mg/10ml (0.25%) inj ampoules
1502010C0AAABAB
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 1,799 |
|
Bupivacaine 25mg/Adrenaline (base) 50microg/10ml inj amp
1502010C0AAAIAI
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 1,410 |
|
Bupivacaine 50mg/10ml (0.5%) solution for injection ampoules
1502010C0AAADAD
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 862 |
|
Marcain 0.25% inj 10ml Polyamp Steripack ampoules
1502010C0BBAIAB
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | 521 |
|
Marcain 0.5% inj 10ml Polyamp Steripack ampoules
1502010C0BBAJAD
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | 367 |
|
Bupivacaine 0.25% inj 10ml Sure-Amp ampoules
1502010C0BCABAB
|
Sure-Amp Bupivacaine hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 74 |
|
Marcain Heavy 0.5% solution for injection 4ml ampoules
1502010C0BBAHAK
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | 22 |
|
Bupivacaine 20mg/4ml (0.5%) / Glucose 320mg/4ml inj ampoules
1502010C0AAAKAK
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | 6 |
|
Bupivacaine 0.5% inj 10ml Sure-Amp ampoules
1502010C0BCAAAD
|
Sure-Amp Bupivacaine hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 0.75% inj 10ml Sure-Amp ampoules
1502010C0BCACAE
|
Sure-Amp Bupivacaine hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 100mg/100ml (0.1%) infusion bags
1502010C0AAAXAX
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 250mg/250ml (0.1%) infusion bags
1502010C0AAAYAY
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 312.5mg/250ml (0.125%) infusion bags
1502010C0AAALAL
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 75mg/10ml (0.75%) inj ampoules
1502010C0AAAEAE
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Marcain 0.25% with Adrenaline 50microg/10ml inj amp
1502010C0BBAFAI
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Marcain 0.5% with Adrenaline 50microg/10ml inj amp
1502010C0BBAGAJ
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.